跳至主要内容
临床试验/JPRN-UMIN000053183
JPRN-UMIN000053183招募中Unknown

Multicenter prospective observational study of immune checkpoint inhibitor based therapy in advanced esophageal cancer patients with dysphagia - Multicenter prospective observational study of immune checkpoint inhibitor based therapy in advanced esophageal cancer patients with dysphagia

Toyama University Hospital0 个研究点目标入组 40 人开始时间: 2023年12月21日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Expected prognosis of less than 3 months 2) History of receiving checkpoint inhibitor therapy 3) History of radiation therapy to the primary esophageal cancer, or planned concurrent chemoradiation therapy 4) Presence of uncontrollable comorbidities or serious complications 5) Presence of a mental disorder that makes it difficult to complete questionnaires 6) Considered unsuitable for enrollment in this study by the attending physician

研究者

相似试验